Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Blood|November 22, 2014
Fc-optimized antibodies quickly pull the triggerChristian Kellner, Matthias Peipp
Cancer Letters|September 18, 2004
Nitric oxide is synthesized in acute leukemia cells after exposure to phenolic antioxidants and initially protects against mitochondrial membrane depolarizationChristian Kellner, Susan J Zunino
Oncoimmunology|July 30, 2013
Promoting natural killer cell functions by recombinant immunoligands mimicking an induced self phenotypeChristian Kellner, Martin Gramatzki, Matthias Peipp
Hearing Research|September 2, 2003
Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluidAlec N Salt, Christian Kellner, Shane Hale
Methods (San Diego, Calif.)|July 16, 2013
Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functionsChristian Kellner, Stefanie Derer, Thomas Valerius, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Fc engineering: design, expression, and functional characterization of antibody variants with improved effector functionStefanie Derer, Christian Kellner, Sven Berger, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 27, 2017
Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer TherapyChristian Kellner, Anna Otte, Elisa Cappuzzello, et al.
Oncoimmunology|September 18, 2018
Perspectives of Fc engineered antibodies in CD19 targeting immunotherapies in pediatric B-cell precursor acute lymphoblastic leukemiaChristian Kellner, Matthias Peipp, Martin Gramatzki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2004
Age-dependent thickening of glomerular basement membrane has no major effect on glomerular hydraulic conductivityKlaus H Neumann, Christian Kellner, Karlwilhelm Kühn, et al.
Clinical and Experimental Immunology|March 24, 2022
Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancerMatthias Peipp, Katja Klausz, Ammelie Svea Boje, et al.
Pageof 8